Minaris Regenerative Medicine is a leading global contract development and manufacturing organization (CDMO) dedicated to the production of cell and gene therapy products. For more than 20 years, we have been offering clinical and commercial manufacturing services, development solutions, and technologies while providing outstanding quality and reliability. Our Vision: Creating Future Cell Therapy Miracles Together. Our state-of-the-art facilities located within the United States (New Jersey and California), Europe (Germany), and Asia (Japan) allow us to supply patients worldwide with life-changing therapies. As a pioneer within this industry, we are proud to have built strong relationships with a number of international clients, ranging from big pharma to biotech to academia.
This company is:
Verified
QP Batch Certification | Minaris Regenerative Medicine
For cell and gene therapy products manufactured outside the European Union, Minaris Regenerative Medicine offers batch release to the EU market by Qualified Persons (QP).
Verified
Chargenzertifizierung | Minaris Regenerative Medicine
For cell and gene therapy products manufactured outside the European Union, Minaris Regenerative Medicine offers batch release to the EU market by Qualified Persons (QP).
Verified
QP(Qualified Person) バッチ認証 | Minaris Regenerative Medicine
For cell and gene therapy products manufactured outside the European Union, Minaris Regenerative Medicine offers batch release to the EU market by Qualified Persons (QP).
View all products
Keywords
Industries
Minaris Regenerative Medicine Streamlining Contract Manufacturing with Veeva Vault Quality Suite Applications
Veeva Systems (NYSE: VEEV) today announced that Minaris Regenerative Medicine, a leading contract development and manufacturing organization (CDMO) focused on cell and gene therapies, selected Veeva Vault QualityDocs and Veeva Vault Training to advance its global quality operations. Minaris Regenerative Medicine will use Veeva’s unified quality applications to better collaborate with customers and partners, improve transparency across functions, and ensure compliance.
Where is Minaris Regenerative Medicine located?
The company Minaris Regenerative Medicine is located in Tokyo, Tokyo, Japan. It's worth noting that the company may has more corporate locations
How many employees does Minaris Regenerative Medicine approximately have?
As of the latest available information Minaris Regenerative Medicine has around 501-1000 employees worldwide.
In which industries does Minaris Regenerative Medicine mainly work?
The company Minaris Regenerative Medicine has it's main focus in the industries of Pharmaceuticals
What is the current company status of Minaris Regenerative Medicine?
Based on the founding year and the amount of employees the company Minaris Regenerative Medicine seems to be a Medium-Sized Company at the current state. Note that over time that status can change
apceth Biopharma
Germany
11-50 Employees
2007
View
Alliance Regenerative Medicine
United States
11-50 Employees
2009
View
Matica Biotechnology, Inc.
United States
11-50 Employees
2019
View
Miltenyi Biomedicine
Germany
51-100 Employees
2019
View
ImmuneCyte Inc.
United States
51-100 Employees
View
CellMP
United States
1-10 Employees
View
Centre for Commercialization of Regenerative Medicine
Canada
101-250 Employees
2011
View
Selexis
Switzerland
11-50 Employees
2001
View
Topics which have been searched by others and may be interesting for you:
